These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26646794)

  • 1. Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study.
    Zhang J; Cai Y; Hu H; Lan P; Wang L; Huang M; Kang L; Wu X; Wang H; Ling J; Xiao J; Wang J; Deng Y
    Oncotarget; 2016 Jan; 7(4):5053-62. PubMed ID: 26646794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
    Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
    World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms to predict tumor regression grade (TRG) and ypTNM staging in patients with locally advanced esophageal cancer receiving neoadjuvant therapy.
    Qiu J; Zhang Z; Liu J; Zhao Y; Li Y; Tang Z; Li L; Tian Y; Tian H
    World J Surg Oncol; 2024 Jul; 22(1):198. PubMed ID: 39068445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
    Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation.
    Bensignor T; Brouquet A; Dariane C; Thirot-Bidault A; Lazure T; Julié C; Nordlinger B; Penna C; Benoist S
    Colorectal Dis; 2015 Jun; 17(6):491-8. PubMed ID: 25524450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
    J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
    Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
    Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Wang G; Li J; Huang Y; Guo Y
    Cancer Med; 2024 Jun; 13(11):e7251. PubMed ID: 38819440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.
    Wei FZ; Mei SW; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Liu Z; Liu Q
    World J Gastroenterol; 2020 Nov; 26(42):6638-6657. PubMed ID: 33268952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
    Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
    Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Delaloge S; Gonzalez-Angulo AM; Andre F; Hess KR; Buzdar AU; Garbay JR; Spielmann M; Mathieu MC; Symmans WF; Wagner P; Atallah D; Valero V; Berry DA; Hortobagyi GN
    J Clin Oncol; 2005 Nov; 23(33):8331-9. PubMed ID: 16293864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
    De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
    Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
    Weiss C; Arnold D; Dellas K; Liersch T; Hipp M; Fietkau R; Sauer R; Hinke A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):472-8. PubMed ID: 20133081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
    Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
    World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.